Barclays raised the firm’s price target on Keurig Dr Pepper (KDP) to $38 from $37 and keeps an Overweight rating on the shares. The firm thinks Keurig’s ability to reiterate its prior 2025 guidance “will prove unique this earnings season.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Keurig Dr Pepper Announces Board Leadership Changes
- China weighs U.S. tariff exemptions, Alphabet reports Q1 beat: Morning Buzz
- Keurig upgraded, Global Payments downgraded: Wall Street’s top analyst calls
- HSBC upgrades ‘steady’ Keurig Dr Pepper to Buy
- Keurig Dr Pepper upgraded to Buy from Hold at HSBC